Dornase Alpha for the Treatment of COVID-19
Clinical trial NCT04432987 · UNKNOWN
Trial details
- NCT number
- NCT04432987
- Sponsor
- Acibadem University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-25
- Primary completion
- 2020-08-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.